nfants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study.
Related posts:
- New drug regimens cut HIV spread from mother to infant Pregnant women who are unaware that they have HIV miss the chance for drug treatment that can benefit not only their own health, but could also prevent them from transmitting the virus to their infants. When HIV is not diagnosed until women go into labor, their infants are usually treated soon after birth with the […]...
- Medicare, Triplets with extremely low birth weight face high risks Among the smallest preterm infants, those born as triplets are at greater risk than single born infants or twins of dying or developing a disability before their second birthday, according a study by a research network of the National Institutes of Health....
- Vitamin D may improve bone health in those taking anti-HIV drug Vitamin D may help prevent hormonal changes that can lead to bone loss among those being treated for HIV with the drug tenofovir, according to the results of a National Institutes of Health network study of adolescents with HIV....
- Researchers show how anti-HIV drug acts to block herpes virus An anti-HIV drug also discovered to stop the spread of the genital herpes virus does so by disabling a key DNA enzyme of the herpes virus, according to findings by researchers at the National Institutes of Health and other institutions....
- Steroids boost survival, reduce brain injury for infants born at 23 weeks Prenatal steroids — given to pregnant women at risk for giving birth prematurely — appear to improve survival and limit brain injury among infants born as early as the 23rd week of pregnancy, according to a study by a National Institutes of Health research network....
- Progesterone reduces rate of early preterm birth in at risk women A National Institutes of Health study has found that progesterone, a naturally occurring hormone, reduced the rate of preterm birth before the 33rd week of pregnancy by 45 percent among one category of at risk women....
- Six-month drug regimen cuts HIV isk for breastfeeding infants Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today....
- Medicare: Cholesterol levels elevated in toddlers taking anti-HIV drugs Toddlers receiving anti-HIV drugs have higher cholesterol levels, on average, than do their peers who do not have HIV, according to researchers at the National Institutes of Health and other institutions....
- Pregnancy and 2009 H1N1 Flu: Protect Yourself, Protect Your Baby Pregnant women can get seriously ill with the 2009 H1N1 ...
- Medicare, Independent panel discourages routine use of treatment regimen for premature infants Premature infants often suffer from respiratory problems due to their underdeveloped lungs. Over the past decade, many of these infants have been treated with inhaled nitric oxide — a treatment designed to ease breathing by widening blood vessels in the lungs. This week, an independent panel convened by the National Institutes of Health determined that […]...
- Placental, pregnancy conditions account for most stillbirths Half of all stillbirths result from pregnancy disorders and conditions affecting the placenta, according to results reported by a National Institutes of Health network established to find the causes of stillbirth as well as ways to prevent or reduce its occurrence....
- Text4baby — Text Messages for Pregnant Women and New Parents Text4baby is a free service from the Centers for Disease Control and Prevention (CDC) that provides pregnant women and new parents with pregnancy and baby care tips. Sign up by texting BABY to 511411 (or BEBE in Spanish) and you’ll receive weekly SMS text messages throughout your pregnancy and up through the baby’s first year […]...
- Study links high levels of cadmium, lead in blood to pregnancy delay Higher blood levels of cadmium in females, and higher blood levels of lead in males, delayed pregnancy in couples trying to become pregnant, according to a study by researchers at the National Institutes of Health and other academic research institutions....
- Medicare, Gene Pattern, May Identify Kidney Transplant Recipients, Who Don’t Need Life-long Anti-rejection Drugs Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 […]...
- MedicareCard.com, Experimental Immune, Boosting Drug Worsens TB in Mice An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online....